Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LCK | P06239 | 16/20 | 0.69 |
| ▸ | MAPK14 | Q16539 | 8/20 | 0.68 |
| ▸ | MAPK13 | O15264 | 2/20 | 0.61 |
| ▸ | EGFR | P00533 | 2/20 | 0.61 |
| ▸ | FYN | P06241 | 2/20 | 0.61 |
| ▸ | HCK | P08631 | 2/20 | 0.61 |
| ▸ | SRC | P12931 | 2/20 | 0.61 |
| ▸ | JAK3 | P52333 | 2/20 | 0.61 |
| ▸ | MAPK12 | P53778 | 2/20 | 0.61 |
| ▸ | MAPK11 | Q15759 | 2/20 | 0.61 |
| ▸ | ABL1 | P00519 | 1/20 | 0.60 |
| ▸ | ERBB2 | P04626 | 1/20 | 0.60 |
| ▸ | YES1 | P07947 | 1/20 | 0.60 |
| ▸ | LYN | P07948 | 1/20 | 0.60 |
| ▸ | FGR | P09769 | 1/20 | 0.60 |
| ▸ | KIT | P10721 | 1/20 | 0.60 |
| ▸ | BCR | P11274 | 1/20 | 0.60 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL774498 | 0.91 | LCK (0.76) | LCKMAPK14MAPK13EGFRFYN | |
| SCHEMBL774360 | 0.87 | LCK (0.70) | LCKMAPK14MAPK13EGFRFYN | |
| SCHEMBL12703161 | 0.86 | LCK (0.73) | LCKMAPK14MAPK13EGFRFYN | |
| SCHEMBL31727502 | 0.86 | LCK (0.67) | LCKMAPK14MAPK13EGFRFYN | |
| SCHEMBL775063 | 0.85 | LCK (0.74) | LCKMAPK14MAPK13EGFRFYN | |
| SCHEMBL774109 | 0.83 | LCK (0.73) | LCKMAPK14MAPK13EGFRFYN | |
| SCHEMBL774063 | 0.83 | MAPK14 (0.65) | LCKMAPK14MAPK13EGFRFYN | |
| SCHEMBL2774894 | 0.82 | LCK (0.83) | LCKMAPK14MAPK13EGFRFYN | |
| SCHEMBL774932 | 0.82 | LCK (1.00) | LCKMAPK14MAPK13EGFRFYN | |
| SCHEMBL775040 | 0.81 | LCK (0.70) | LCKMAPK14MAPK13EGFRFYN |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2308833-A2 | Cyclic protein tyrosine kinase inhibitors | Bristol-Myers Squibb Company (US) | 2011-04-13 | — | — | EP | claimed |